R v Licensing Authority Established under Medicines Act 1968, ex parte Smith Kline & French Laboratories Ltd

Core Citations

CONSIDERS

• Medicines Act 1968
• Medicines Act 1968 - Articles : S-6
• Medicines Act 1968 - Articles : S-7

[See more]

• Medicines Act 1968 - Articles : S-20
• Patents Act 1977
• Medicines Act 1968 - Articles : S-28

CITES

• Farbwerke Hoechst AG (Sturm and Others') Patent

[See more]

• Re Allen & Hanburys Ltd's (Salbutamol) Patent
• Syntex Corporation's (Naproxen) Patent

REPORTED OPINION OF in

• [1989] 1 All ER 175
• [1988] 3 CMLR 301
• 5 BMLR 14

[See more]

• [1989] 1 FSR 11
• [1988] 3 WLR 896

REFERRED in

• R v The Licensing Authority, ex parte Novartis
• Swintex Ltd v Melba Products Ltd
• R v Ministry of Agriculture, Fisheries and Food and Another, ex parte Monsanto Plc

[See more]

• R (Zoolife International Ltd) v Secretary of State for Environment, Food and Rural Affairs

CITED in

• Generics (UK) Ltd and Another v Smith Kline and French Laboratories Ltd ; Case C-191/90
• R (Organon Laboratories Ltd) v Department of Health and Social Security and Others

CONSIDERED in

• Organon Laboratories Ltd v Department of Health and Social Security
• R v Licensing Authority Established under Medicines Act 1968, ex parte Smith Kline & French Laboratories Ltd

APPEAL RESOLVED in

• R v Licensing Authority Established under Medicines Act 1968, ex parte Smith Kline & French Laboratories Ltd

This document cites

• Re Allen & Hanburys Ltd's (Salbutamol) Patent
• Syntex Corporation's (Naproxen) Patent
• Farbwerke Hoechst AG (Sturm and Others') Patent
• Medicines Act 1968
• Patents Act 1977



See all quotations

• Criminal proceedings against Frans-Nederlandse Maatschappij voor Biologische Producten BV.
• Adriaan de Peijper, Managing Director of Centrafarm BV.
• Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products
• Council Directive 83/570/EEC of 26 October 1983 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products
• Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products
• Council Directive 87/19/EEC of 22 December 1986 amending Directive 75/318/EEC on the approximation of the laws of the Member States relating to analytical, pharmaco- toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products
• Council Directive 87/21/EEC of 22 December 1986 amending Directive 65/65/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products